Feb 01, 2021
Applied Therapeutics Announces Restart of Pediatric Galactosemia Study
FDA Clinical Hold Lifted NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced
Displaying 21 - 21 of 21


Print Page
Print Page
Email Alerts
RSS Feeds
RSS Feeds
Contact IR
Contact IR
AP_logo_KO
linkedin
facebook
twitter

©2021 Applied Therapeutics All Rights Reserved

linkedin
facebook
twitter
AP_logo_KO

©2021 Applied Therapeutics All Rights Reserved